ESR Positions and application details

Queen's University Belfast

Closing date: Monday 9 January 2017.

Anticipated interview date: Friday 27 January 2017.

Queen’s University Belfast, United Kingdom - Prof Moira Dean and Dr Lisa Connolly.

ESR1 will focus on exploring consumer perceptions and understanding of EDs in in the environment and food chain for the development of efficient risk communication strategies. This project will involve the use of qualitative focus group and survey methods for validation.

For further information contact:  Mrs Joyce Watterson (joyce.watterson@qub.ac.uk)  

APPLY ONLINE via the QUB application portal (Ref: 16/105007).

Norwegian Institute of Public Health, Oslo, Norway - Prof Merete Eggesbø.

ESR2 will focus on epidemiological data to identify mixtures of contaminants associated with adverse child health outcomes. This project will involve the use of data analysis software and statistical analysis.

For further information contact: Prof Merete Eggesbø (Merete.Eggesbo@fhi.no).

APPLY ONLINE via the NIPH application portal.

The University of Aberdeen, United Kingdom - Prof Paul Fowler.

ESR3 will focus on investigating the health impacts of complex chemical mixtures on human foetal and placental health. This project will involve the analysis of key functional genes in various tissues and bioinformatics including proteomics and transcriptomics.

For further information contact: Prof Paul Fowler (p.a.fowler@abdn.ac.uk).

APPLY ONLINE via the UNIABDN application portal.

Queen’s University Belfast, United Kingdom - Prof Chris Elliott and Dr Lisa Connolly.

ESR4 will focus on determining farm animal exposure to a large number of mycotoxins This project will involve mass spectrometry analysis of mycotoxins in animal feed and biological samples plus the assessment of novel mycotoxin binders.

For further information contact:  Mrs Joyce Watterson (joyce.watterson@qub.ac.uk)  

APPLY ONLINE via the QUB application portal (Ref: 16/105006).

University of Liege, Belgium - Dr Marc Muller.

ESR5 will focus on zebrafish larvae tests for the study of ED mixture effects on early development and behaviour and gene regulation events, especially in the brain. Candidate genes for ED biomarkers may be identified, providing important ecotoxicological information concerning effects on the vertebrate aquatic fauna. This project will involve the use of in vivo zebrafish larvae tests and molecular biology techniques.

For further information contact: Dr Marc Muller (m.muller@ulg.ac.be).

APPLY by sending a CV and letter of motivation to Dr Marc Muller (m.muller@ulg.ac.be).

National Institute for Agricultural Research (INRA), Toulouse, France - Dr Isabelle Oswald.

ESR6 will focus on exploring the effects of the mycotoxin Zearalenone and co-occurring mycotoxin mixtures on the function of the intestine. This project will involve the use of tissue culture techniques and high throughput assays such as transcriptomics.

For further information contact: Dr Isabelle Oswald (Isabelle.Oswald@toulouse.inra.fr).

APPLY by sending a CV and letter of motivation to Dr Isabelle Oswald (Isabelle.Oswald@toulouse.inra.fr).

Norwegian University of Life Sciences, Oslo, Norway - Prof Erik Ropstad.

ESR7 will focus on the effects of defined realistic ED mixtures on gut microbiota composition, neurodevelopment and behaviour in mice. This project will involve the use of rodent animal models, microbiology, molecular biology and cell culture techniques.

For further information contact: Prof Erik Ropstad (erik.ropstad@nmbu.no).

APPLY by sending a CV and letter of motivation to Prof Erik Ropstad (erik.ropstad@nmbu.no).

Norwegian University of Life Sciences, Oslo, Norway - Prof Erik Ropstad.

ESR8 will use Zebrafish models in studies of exposure effects of ED and realistic mixtures thereof. Behavioural outcomes, combined with morphology and transcriptomics studies will be used to investigate exposure effects on neurodevelopment, immune function and their interactions. In addition, transgenerational studies and population modelling will be carried out to investigate population level effects.

For further information contact: Prof Erik Ropstad (erik.ropstad@nmbu.no).

APPLY by sending a CV and letter of motivation to Prof Erik Ropstad (erik.ropstad@nmbu.no).

University of Liege, Belgium - Prof Marie-Louise Scippo.

ESR9 will focus on assessing the impact of exposure to mixtures of chemicals found in drinking water on the Aryl hydrocarbon receptor. This project will involve the use of cell culture, biomarker identification and proteomics.

For further information contact: Prof ML Scippo (mlscippo@ulg.ac.be).

APPLY by sending a CV and letter of motivation to Prof ML Scippo (mlscippo@ulg.ac.be).

Norwegian Veterinary Institute, Oslo, Norway - Dr Gunnar Eriksen and Dr Christopher Miles.

ESR10 will focus on screening cyanobacteria for ED activity. This project will involve the use of high-resolution LC-MS and NMR methods.

For further information contact: Dr Christopher Miles (chris.miles@vetinst.no).

APPLY by sending a CV and letter of motivation to Dr Christopher Miles (chris.miles@vetinst.no).

ProtoQSAR SL, Valencia, Spain - Dr Rafael Gozalbes.

ESR11 will focus on the development of predictive QSAR models for ED mixtures. This project will involve the use of innovative QSAR tools and virtual screening technology.

For further information contact: Dr Rafael Gozalbes (rgozalbes@protoqsar.com).

APPLY by sending a CV and letter of motivation to Dr Rafael Gozalbes (rgozalbes@protoqsar.com).

Austral University of Chile, Chile - Dr Gudrun Kausel.

ESR12 will focus on developing non-invasive assays to assess in vivo biomarkers in fish. This project will involve the use of molecular biology technique analysis.

For further information contact: Dr Gudrun Kausel (gkausel@uach.cl).

APPLY by sending a CV and letter of motivation to Dr Gudrun Kausel (gkausel@uach.cl).

Queen’s University Belfast, United Kingdom - Dr Lisa Connolly.

ESR13 will focus on developing state-of-the-art high content analysis assays for the investigation of ED and their mixture effects on cellular health and disease pathways. This project will involve the use of cell culture techniques and in vitro bioassay development.

For further information contact:  Mrs Joyce Watterson (joyce.watterson@qub.ac.uk)  

APPLY ONLINE via the QUB application portal (Ref: 16/105004).

BioDetection Systems, Amsterdam, The Netherlands - Dr Bart Van der Burg.

ESR14 will focus on the development of a combined chemical-biological detection system for ED mixtures affecting human development. This project will involve the use of analytical detection systems, cell culture techniques and in vitro bioassay development.

For further information contact: Dr Bart Van der Burg (Bart.van.der.Burg@bds.nl).

APPLY by sending a CV and letter of motivation to Dr Bart Van der Burg (Bart.van.der.Burg@bds.nl).

BioDetection Systems, Amsterdam, The Netherlands - Dr Bart Van der Burg.

ESR15 will focus on the development of a combined chemical-biological detection system for ED mixtures affecting animal reproduction. This project will involve the use of analytical detection systems, cell culture techniques and in vitro bioassay development.

For further information contact: Dr Bart Van der Burg (Bart.van.der.Burg@bds.nl).

APPLY by sending a CV and letter of motivation to Dr Bart Van der Burg (Bart.van.der.Burg@bds.nl).